Samanta P, Ghorai S
In Silico Pharmacol. 2025; 13(1):25.
PMID: 39944120
PMC: 11811331.
DOI: 10.1007/s40203-025-00313-9.
Nada H, Meanwell N, Gabr M
Expert Opin Drug Discov. 2025; 20(2):145-162.
PMID: 39862145
PMC: 11844436.
DOI: 10.1080/17460441.2025.2458666.
Syahdi R, Jasial S, Maeda I, Miyao T
ACS Omega. 2024; 9(37):38957-38969.
PMID: 39310180
PMC: 11411525.
DOI: 10.1021/acsomega.4c05433.
Nithyasree V, Magdalene P, Praveen Kumar P, Preethi J, Gromiha M
Mol Biotechnol. 2024; .
PMID: 39162909
DOI: 10.1007/s12033-024-01251-1.
Verma M, Sarfraz A, Hasan I, Vasudev P, Khan F
Med Chem. 2024; 20(6):646-661.
PMID: 38299297
DOI: 10.2174/0115734064247526231129080415.
Fighting Antimicrobial Resistance: Insights on How the NorA Efflux Pump Recognizes 2-Phenylquinoline Inhibitors by Supervised Molecular Dynamics (SuMD) and Molecular Docking Simulations.
Palazzotti D, Felicetti T, Sabatini S, Moro S, Letizia Barreca M, Sturlese M
J Chem Inf Model. 2023; 63(15):4875-4887.
PMID: 37515548
PMC: 10428217.
DOI: 10.1021/acs.jcim.3c00516.
Recent Advances in Computer-Aided Structure-Based Drug Design on Ion Channels.
Pliushcheuskaya P, Kunze G
Int J Mol Sci. 2023; 24(11).
PMID: 37298178
PMC: 10253043.
DOI: 10.3390/ijms24119226.
Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of Cancer.
Ahmed A, Aziz M, Ejaz S, Ali Channar P, Saeed A, Zargar S
Biomolecules. 2022; 12(11).
PMID: 36421710
PMC: 9687900.
DOI: 10.3390/biom12111696.
Emerging Promise of Computational Techniques in Anti-Cancer Research: At a Glance.
Rahman M, Islam M, Rahman F, Rahaman M, Khan M, Abrar S
Bioengineering (Basel). 2022; 9(8).
PMID: 35892749
PMC: 9332125.
DOI: 10.3390/bioengineering9080335.
Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling.
Zagaliotis P, Petrou A, Mystridis G, Geronikaki A, Vizirianakis I, Walsh T
Int J Mol Sci. 2022; 23(14).
PMID: 35887353
PMC: 9325261.
DOI: 10.3390/ijms23148006.
Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system.
Gautam V, Gaurav A, Masand N, Lee V, Patil V
Mol Divers. 2022; 27(2):959-985.
PMID: 35819579
DOI: 10.1007/s11030-022-10489-3.
Machine Learning and Its Applications for Protozoal Pathogens and Protozoal Infectious Diseases.
Hu R, Hesham A, Zou Q
Front Cell Infect Microbiol. 2022; 12:882995.
PMID: 35573796
PMC: 9097758.
DOI: 10.3389/fcimb.2022.882995.
Drugsniffer: An Open Source Workflow for Virtually Screening Billions of Molecules for Binding Affinity to Protein Targets.
Venkatraman V, Colligan T, Lesica G, Olson D, Gaiser J, Copeland C
Front Pharmacol. 2022; 13:874746.
PMID: 35559261
PMC: 9086895.
DOI: 10.3389/fphar.2022.874746.
Drug Design-Past, Present, Future.
Doytchinova I
Molecules. 2022; 27(5).
PMID: 35268598
PMC: 8911833.
DOI: 10.3390/molecules27051496.
A Comparison between Enrichment Optimization Algorithm (EOA)-Based and Docking-Based Virtual Screening.
Spiegel J, Senderowitz H
Int J Mol Sci. 2022; 23(1).
PMID: 35008467
PMC: 8744642.
DOI: 10.3390/ijms23010043.
Drug Discovery for Using Structure-Based Computer-Aided Drug Design Approach.
Ejalonibu M, Ogundare S, Elrashedy A, Ejalonibu M, Lawal M, Mhlongo N
Int J Mol Sci. 2021; 22(24).
PMID: 34948055
PMC: 8703488.
DOI: 10.3390/ijms222413259.
Development of Computational Approaches with a Fragment-Based Drug Design Strategy: In Silico Hsp90 Inhibitors Discovery.
Leon R, Soto-Delgado J, Montero E, Vargas M
Int J Mol Sci. 2021; 22(24).
PMID: 34948022
PMC: 8706391.
DOI: 10.3390/ijms222413226.
Gains from no real PAINS: Where 'Fair Trial Strategy' stands in the development of multi-target ligands.
Sun J, Zhong H, Wang K, Li N, Chen L
Acta Pharm Sin B. 2021; 11(11):3417-3432.
PMID: 34900527
PMC: 8642439.
DOI: 10.1016/j.apsb.2021.02.023.
Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2.
Bajad N, Rayala S, Gutti G, Sharma A, Singh M, Kumar A
Curr Res Pharmacol Drug Discov. 2021; 2:100026.
PMID: 34870145
PMC: 8120892.
DOI: 10.1016/j.crphar.2021.100026.
Rapid Identification of Potential Drug Candidates from Multi-Million Compounds' Repositories. Combination of 2D Similarity Search with 3D Ligand/Structure Based Methods and In Vitro Screening.
Szilagyi K, Flachner B, Hajdu I, Szaszko M, Dobi K, Lorincz Z
Molecules. 2021; 26(18).
PMID: 34577064
PMC: 8468386.
DOI: 10.3390/molecules26185593.